- Issuer ticker
-
BVS
- Reported as of
-
15 Feb 2026
- Net transaction value
-
-$77,978
- SEC form
-
4
- Accepted by SEC
-
18 Feb 2026, 18:30:05 UTC
Filing notes and source
Key filing fact
Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 18 Feb 2026.
Key facts
- This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Feb 2026, 18:30.
Change
- Previous filing in this sequence was filed on 15 Apr 2025.
- Current net transaction value: -$77,978.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001914936
Primary reporting owner
Singleton Mark Leonard
- Relationship
-
SVP & CFO
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BVS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +20,153
- Change %
- +14%
- Price
-
$0.000000
- Shares after
- 161,241
- Date
- 15 Feb 2026
- Ownership
- Direct
BVS
transaction
Class A Common Stock
Tax liability
- Transaction value
- -$77,978
- Shares
- -9,429
- Change %
- -5.8%
- Price
-
$8.27
- Shares after
- 151,812
- Date
- 15 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BVS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -20,153
- Change %
- -33%
- Price
-
$0.000000
- Shares after
- 40,304
- Date
- 15 Feb 2026
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 20,153
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes